# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighti...
Telomir Pharmaceuticals' stock rises as Telomir-1 shows strong lab results against aggressive triple-negative breast cancer...
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage biotechnology com...
DAL: 6% | Delta Air Lines shares are trading higher after the company reported better-than-expected Q3 financial results and ra...